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Interleukin-6 and Nitric Oxide Levels in
Neonatal Sepsis*
Aim: The objectives of this study were to compare interleukin-6 (IL-6) and nitric oxide (NO) levels in newborns
with culture-proven sepsis with levels in age- and gestational age (GA)-matched controls, and to investigate
the correlation between mediator levels and circulatory functions in the septic group.
Materials and Methods: Samples for IL-6 and NO levels were obtained from newborns with blood cultureproven sepsis before the beginning of antibiotic therapy and on the 3rd day of treatment. Heart rate, blood
pressure and other treatment modalities including inotropic support were also recorded. Age- and GA-matched
newborns without infection were included as controls. Minitab 13.0 was used for statistical analysis.
Results: Eighteen septic and 23 control patients were included in the study. IL-6 and NO levels were
significantly higher in septic patients, and low blood pressure as a sign of the circulatory effects of sepsis was
rd
found to be negatively correlated with IL-6 levels on the 3 day of treatment in newborns with septic shock.
No correlation was found between clinical findings and NO levels.
Conclusions: IL-6 and NO levels were high in septic newborns as expected; however, circulatory findings were
only correlated with IL-6 levels on the 3rd day of treatment in the septic shock group, suggesting that systemic
inflammatory response syndrome (SIRS) is an ongoing process during infection in this subgroup. NO probably
plays its major role much earlier as a defense mechanism in the complex chain of events during SIRS.
Key Words: Nitric oxide, IL-6, newborn, sepsis

Sepsisli Yenido¤anlarda ‹nterlökin 6 ve Nitrik Oksit Düzeyleri
Amaç: Bu çal›ﬂman›n amac› kan kültüründe üreme olan sepsisli yenido¤anlarda interlökin 6 (IL6) ve nitrik oksit
(NO) düzeylerini ölçerek gebelik yaﬂ› ve postnatal yaﬂ› hasta grubuyla benzer olan kontrol grubuyla
karﬂ›laﬂt›rmak ve sepsisli bebeklerdeki mediatör düzeyleri ile kardiyovasküler sistem bulgular› aras›ndaki iliﬂkiyi
araﬂt›rmakt›r.
Yöntem ve Gereç: Sepsisli yenido¤anlardan tedavi öncesinde ve tedavinin 3. gününde IL6 ve NO düzeyleri için
kan örnekleri al›nm›ﬂt›r. Ayr›ca hastalar›n kalp at›m h›zlar›, kan bas›nçlar›, almakta olduklar› dolaﬂ›m deste¤i
tedavileri kaydedilmiﬂtir. Kontrol grubu olarak , hastalar›n gebelik yaﬂ› ve postnatal yaﬂ›na benzer özellik
gösteren ve enfeksiyon d›ﬂ› nedenlerle izlenen yenido¤anlar al›nm›ﬂt›r. ‹statistiksel analiz için Minitab 13.0
program› kullan›lm›ﬂt›r.
Bulgular: Çal›ﬂmaya 18 sepsisli, 23 kontrol al›nm›ﬂt›r. Hasta grubunun IL6 ve NO düzeyleri kontrol grubuna
göre yüksek bulunmuﬂtur. Sepsisin yol açt›¤› dolaﬂ›m bozuklu¤unun bir göstergesi olarak al›nan kan bas›nc›
tedavinin 3. günündeki IL6 düzeyi ile negatif korelasyon göstermiﬂtir. NO düzeyleri ile klinik bulgular aras›nda
korelasyon bulunmam›ﬂt›r.
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Sonuç: IL6 ve NO düzeyleri sepsisli yenido¤anlarda kontrol grubuna göre yüksek bulunmuﬂtur.Ancak k›sa
sürede düﬂmesi beklenen IL6 düzeyleri septik ﬂoklu hastalarda 3. günde halen yüksek kal›p kan bas›nc› ile
negatif korelasyon göstermiﬂtir. Bu durum septik ﬂoklu hastalarda sistemik inflamatuvar yan›t sendromunun
(SIRS) halen devam etti¤ini göstermektedir.Öte yandan NO klinik etkilerini hastal›¤›n çok daha erken
döneminde kompleks bir mekanizma içinde gösteriyor olabilir.
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Introduction

Materials and Methods

In the pediatric population, the definition of sepsis and
related clinical conditions have been revised and modified
usually parallel to changes in definitions in the adult
population. According to the recent literature, pediatric
sepsis is defined as systemic inflammatory response
syndrome (SIRS) with infection, severe sepsis as sepsis
together with organ dysfunction (hypoxia, acidosis,
hypoperfusion, oliguria), and septic shock as sepsis
together with hypotension-hypoperfusion despite fluid
resuscitation (1).

Newborns who had clinical signs of sepsis were
considered eligible for the study. In addition to sepsis
work-up consisting of whole blood count, CRP, and blood
cultures, which were performed in all, an additional 1 cc
venous sampling was obtained for determination of IL-6
rd
and NO levels. The same studies were repeated at the 3
th
day of antibiotic treatment (at the end of the 48 hour).
Infants who had positive blood cultures remained in the
study group and those whose blood cultures were
negative were excluded. Healthy newborns of the same
gestational and postnatal age who were hospitalized for
reasons other than infection were included as the control
group and 1 cc of blood was drawn for determining IL-6
and NO levels. The study was approved by the hospital
ethics committee and informed parental consent was
obtained. All blood samples were centrifuged at 3500
rpm (revolutions per minute) for 5 minutes, and serum
was separated and stored at -70°C.

In sepsis, depending on the activation of the
complement, contact activation, and the intrinsic
coagulation systems, many mediators like interleukin-6
(IL-6), nitric oxide (NO), and tumor necrosis factor-α
(TNF-α) are released (2) and have been shown to play
different roles in the clinical course of the disease in a
time-dependent manner.
IL-6 plays many roles in the inflammatory response in
relation with the pathogenesis of bacterial infections.
Studies have shown that plasma IL-6 levels increase by
64-100% in cases with sepsis (3,4). It is the major
regulator of acute protein response. In liver cells, it
stimulates the synthesis of C-reactive protein (CRP),
serum amyloid A, α1-acid glycoprotein, α1-antitrypsin,
and fibrinogen, and is also responsible for myocardial
depression (5).
NO is synthesized from oxygen and arginine by NO
synthase. During septic shock, endothelium releases
abundant NO as a response to endotoxin, platelet
activating factor (PAF), IL-1, and TNF-α (6-8), resulting
in vasodilatation, inhibition of platelet aggregation,
inhibition of smooth muscle cell proliferation, and
decreased endothelial expression of proinflammatory
mediators.
NO production i) increases in sepsis and septic shock
of the newborn and pediatric patients (9,10), ii) is
correlated with the severity of disease and the degree of
inflammation (9,11,12), and iii) increases with the
initiation of sepsis and decreases in the recovery period
(9). The objective of this study was to measure IL-6 and
NO levels in patients with culture-proven sepsis before
treatment and 48 hours into treatment and assess the
correlation between mediator levels and clinical findings.
262

According to the clinical course, patients were divided
into three groups as sepsis, severe sepsis and septic
shock, and intergroup differences were recorded.
Measurement of IL-6 Levels
IL-6 measurements were performed with sandwich
ELISA method by BioSource International, Inc. hIL-6 kit.
Serum samples, standard solutions and control
samples were introduced to the medium enclosed with
specific IL-6 antibody and biotinized monoclonal IL-6
antibody was added to the top. After incubation at room
temperature for 2 hours, the liquid formed on the top
was removed and the plate was washed and streptavidinperoxidase enzyme complex was added to every
measurement space. After incubation at room
temperature for 30 minutes, the plate was washed again
in an appropriate manner and chromogen was added to
every measurement space and blue color formation was
observed. After waiting at room temperature for 30
minutes, stop solution was added to every measurement
space and in 2 hours they were read by ELISA reader at
450 nm wavelength.
Measurement of NO Levels
The amount of total nitrate in the test samples was
determined by a modification of the procedure described
by Brahman and Hendrix (13), using the purge system of
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a Sievers Instruments Model 280A Nitric Oxide Analyzer.
Plasma samples were deproteinized using chilled 96%
ethanol (plasma/ethanol = 1/2 vol/vol) before use. A
saturated solution of VCL3 (Vanadium III chloride) in 1M
HCL (800 mg/dl) was prepared and filtered before use.
Five milliliters of this reagent were added to the purge
vessel and purged with nitrogen gas for 10 minutes prior
to use. The purge vessel was equipped with a cold water
condenser and a water jacket to permit heating of the
reagent to 95 ºC using a circulating water bath. The HCL
vapors were removed by a gas bubbler containing 15 ml of
1M NaOH. The gas flow rate into the chemiluminescence
detector was controlled using a needle valve.
Samples were injected into the purge vessel to react
with the VCL3/HCL reagent, which converted nitrate to
NO. The NO produced was stripped from the reaction
chamber
and
detected
by
ozone-induced
chemiluminescence in the chemiluminescence detector.
Ppb (parts per billion) values detected and NO levels in
samples were calculated from the peak values. A standard
curve was constructed using various concentrations of
–
NO3 (10mM to 100µM). Nitrate levels in samples were
calculated by using the standard curve.
Statistics
Minitab statistics program version 13.0 was used for
statistical analysis.
Differences between sepsis and control groups were
determined with Mann- Whitney U test and P < 0.05 was
accepted as statistically significant. Differences within the
sepsis group on days 1 and 3 were determined by
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Wilcoxon Signed Rank test and P < 0.05 was considered
significant.
In the sepsis group, within days, the relations
between clinical findings and IL-6 and NO levels were
evaluated using Pearson correlation analysis, the linear
relation of the investigated parameters was tested
previously, and values with appropriate correlation
coefficients were accepted as significant if P was
determined <0.05. Patients with sepsis, severe sepsis,
and septic shock were analyzed within the same group by
Wilcoxon Signed Rank test and Pearson correlation.
Mann-Whitney U test was used for group comparisons.

Results
Eighteen babies with positive blood cultures were
included in the sepsis group. The microorganism species
found in positive blood cultures were as follows:
Klebsiella spp. (n = 7), coagulase negative staphylococcus
(CNS) (n = 3), E. coli (n = 2), Serratia spp. (n = 2),
Acinetobacter spp. (n = 2), Candida non-albicans (n = 1),
and α-hemolytic streptococcus (n = 1).
Twenty-three babies with gestational and postnatal
ages similar to those of the 18 septic babies and without
any findings of infection were included in the control
group. Gestational age (GA), birth weight (BW) and
postnatal age of babies in the sepsis and control groups
are shown as mean ± SD (median) in Table 1 together
with the IL-6 and NO levels. IL-6 and NO levels were
higher in the patient group than in the control group on
both the 1st and 3rd days of sepsis.

Table 1. Septic and control newborns.
Sepsis
(n = 18)
mean ± SD (median)

Control
(n = 23)
mean ± SD (median)

P

GA (week)

31.56 ± 4.42 (30)

33.39 ± 3.27 (33)

0.14

BW (gram)

1637 ± 702 (1540)

2146 ± 831 (1690)

0.03

Postnatal age (days)

15.28 ± 15.38 (9)

13.04 ± 10.02 (10)

0.89

263 ± 222.5 (157.4) (day 1)

12.95 ± 14.07 (7.8)

<0.0001

IL-6 pg/ml
IL-6 pg/ml

179.7 ± 213.2 (58.7) (day 3)

12.95 ± 14.07 (7.8)

0.0005

NO (µM/L)

53.43 ± 38.87 (47.34) (day 1)

33.8 ± 10.75 (32.04)

0.0044

NO (µM/L)

49.65 ± 30.37 (39.6) (day 3)

33.8 ± 10.75 (32.04)

0.11

GA: Gestational age. BW: Birth weight. IL-6: Interleukin-6. NO: Nitric oxide.
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In the sepsis group on the 1st day of treatment, 10
patients were on inotropic support. At the end of the 48th
hour of therapy (3rd day), 9 patients were on inotropic
support. For inotropic support, dopamine was given to 9
patients, while dopamine + dobutamine combination was
applied in 3 patients according to preference of the
attending physician. When patients with sepsis were
analyzed within themselves, 4 were diagnosed as only
sepsis, 5 as severe sepsis, and 9 as septic shock.
As findings in the severe sepsis and sepsis groups
were very similar, they were combined for statistical
analysis. Maximum heart rate, minimum blood pressure,
and IL-6 and NO levels on the 1st and 3rd days of
treatment in patients with septic shock and those with
severe sepsis and only sepsis are shown in Table 2.
In patients with sepsis and severe sepsis, there was no
correlation between IL-6 and NO levels and vital findings.
rd

In patients with septic shock, IL-6 levels on the 3 day
were found to be negatively correlated with the lowest
blood pressure on the same day (P = 0.033, correlation
coefficient: -74.8%). There was no relation between NO
levels on the 1st and 3rd days and inotropic support or vital
findings on the same days.
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Discussion
Despite the advances in newborn intensive care, the
incidence, morbidity, and mortality of neonatal sepsis are
still high. Sepsis can progress to severe sepsis and septic
shock depending on the degree of severity. Septic shock
is the most important cause of death from sepsis.
In this study, performed with the aim of investigating
the role of mediators on clinical findings during the
course of sepsis in newborns, serum IL-6 levels in septic
st
patients on the 1 day were approximately 20 times
higher than in the control group. Although the IL-6 levels
of the 3rd day were decreased when compared with the
1st day, they were still significantly higher than in the
control group. In the sepsis group, there was no
statistically significant difference between the IL-6 levels
of the 1st and 3rd days, which shows that the SIRS
findings in the patient group persisted.
There was a nearly significant difference between the
IL-6 levels in patients with septic shock and sepsis/severe
sepsis on the 3rd day (P = 0.053). The highest IL-6 levels
were seen in patients with gram-negative sepsis and in
these patients IL-6 levels were high even after the 48th
hour of therapy.

Table 2. Results of patients with septic shock and sepsis/severe sepsis.
Septic shock (n = 9)
mean ± SD (median)

Sepsis/ Severe sepsis (n = 9)
mean ± SD (median)
P

1st day

3rd day

Maximum heart
rate/minute

172.89±15 (168)

156.88±19.74 (151)

Minimum blood
pressure (mmHg)

37.11±9.21 (37)

IL-6 (pg/ml)

NO (µM/L)

P
1st day

3rd day

0.09

165.63±10.64 (164)

154.38±19.8 (159)

0.23

44.63±11.59 (46.5)

0.72

45.5±11.54 (46)

46±7.33 (46)

0.86

358.1 ± 214.8 (500)

271.2 ± 226 (230.1)

0.52

167.9 ± 196.8 (85.6)

88.1 ± 163.3 (20.5)
*P = 0.053

0.01

43.4 ± 13.52 (39.45)

48.81 ± 22.31 (45.57)

0.63

63.5 ± 52.9 (48.5)

50.5 ± 38.2 (37.5)

0.34

IL-6: Interleukin-6. NO: Nitric oxide.
*P: Nearly significant difference between the IL-6 levels in patients with septic shock and those with sepsis/severe sepsis on the 3rd day of the disease.
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In patients with septic shock, the lowest blood
rd
pressure on the 3 day showed a negative correlation
with IL-6 levels. Despite studies suggesting that TNF-α
and IL-1b are responsible for the myocardial depression
in sepsis, a study performed in England including patients
with meningococcal septic shock using genetic analysis
revealed that IL-6 is the primary responsible cytokine in
myocardial depression (5). The higher IL-6 levels in our
patients with septic shock and the relation determined
between these high levels and a decrease in blood
pressure support that this cytokine is responsible for the
myocardial dysfunction in sepsis.
Nevertheless, in this study, serum nitrate levels were
measured and NO levels in the sepsis group before
treatment were found to be statistically higher than in the
control group (p = 0.04). Wong et al. (10) compared the
nitrite and nitrate levels of children with sepsis syndrome
and critically ill children and found that nitrite and nitrate
levels were higher in cases with sepsis and hypotension.
In 1996, Doughty et al. (12) showed the relation
between the increase in IL-6 levels and the increase in
nitrite and nitrate levels in cases with sepsis and organ
failure and hypothesized that increased nitrite and nitrate
levels in sepsis reflected excessive proinflammatory
response.
rd
In this study, there was no difference in 3 day NO
levels between the sepsis and control groups.
Furthermore, there was no difference in NO levels
between the sepsis, severe sepsis and septic shock
patients. In patients with septic shock, there was no
st
rd
relation between the NO levels of the 1 and 3 days and
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the lowest blood pressures or degree of inotropic
support. In addition, there was no relation between
serum IL-6 and NO levels in patients with septic shock.
This can be attributed to the SIRS mechanisms being
more complex in the newborn when compared with other
pediatric age groups. Especially in the patient group
principally consisting of premature patients, these results
can be attributed to some cytokine mechanisms yet being
in the maturation period, and other interactions not yet
being resolved.
In conclusion, in studies performed in newborns to
date, IL-6 and NO levels were demonstrated to increase in
sepsis, and these levels were also increased in our study
in accordance with the literature. It has repeatedly been
reported in the literature that IL-6 increases rapidly
during the onset of sepsis followed by a rapid decline
within 24 hours, which therefore makes it a less useful
marker during the course of the disease (14-16). There
have been discussions as to whether high cytokine levels
are secondary to the inotropes given to support
circulation; however, Oberbeck et al. (17) reported that
IL-6 levels in sepsis are not increased by dopamine. In our
study, IL-6 was found to be negatively correlated with
rd
low blood pressure on the 3 day of the disease in the
septic shock group. This might suggest that in a subgroup
of patients, IL-6 levels remain high, which may be a sign
that SIRS continues in this group, maintaining its adverse
effects on hemodynamics. If this subgroup of patients can
be identified, perhaps with serial IL-6 measurements,
additional individualized supportive treatment modalities
might be developed.
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